Cannavoices Team's Posts (189)

Tech start-ups have already been flocking to the up-and-coming pot trade

 America’s burgeoning weed industry just seems to be climbing higher.

Tech giant Microsoft announced Thursday it is partnering with a cannabis industry-focused software company called Kind Financial. The company provides “seed to sale” services for cannabis growers, allowing them to track inventory, navigate laws and handle transactions all through Kind’s software systems. The partnership marks the first major tech company to attach its name to the burgeoning industry of legal marijuana.

While most big tech companies have been shy to get involved, tech start-ups have been flocking to the up-and-coming pot trade, which is fully legal for both recreational and medical purposes in five states. The marijuana industry’s specific needs for data tracking to optimize plant growth and other logistics, as well as its booming market potential, make it well-suited for tech partnerships. “Nobody has really come out of the closet, if you will,” said Matthew A. Karnes, the founder of marijuana data company Green Wave Advisors, to The New York Times. “It’s very telling that a company of this caliber is taking the risk of coming out and engaging with a company that is focused on the cannabis business.” [Read More]

Read more…

Can Cannabis Cure Autism? [Video]

Can Cannabis Cure Autism?

We don’t know, but it’s a question worth asking.

Judy A. Mikovitz, PhD

Read more…

COLUMBUS, Ohio — Republican Gov. John Kasich signed a bill Wednesday legalizing medical marijuana in Ohio, though patients shouldn’t expect to get it from dispensaries here anytime soon.

The bill lays out a number of steps that must happen first to set up the state’s medical marijuana program, which is expected to be fully operational in about two years. The law would allow patients to use marijuana in vapor form for certain chronic health conditions, but bar them from smoking it or growing it at home.

Kasich’s signature made Ohio the 25th state to legalize a comprehensive medical marijuana program, according to a count by the National Conference of State Legislatures. [Source]

Read more…

The Keurig of Cannabis

CannaKorp Announces World’s First Single-Use, Pod-Based Medical Marijuana Vaporizer System

CannaKorp Announces World’s First Single-Use, Pod-Based

Medical Marijuana Vaporizer System 

CannaCloud™ and CannaCup™ Automated Vaporizer System
Streamline and Revolutionize Use of Medical Marijuana

CannaKorp, Inc. announced it is developing a groundbreaking vaporizer system that will revolutionize the experience for patients taking medical cannabis. CannaKorp’s new offering that uses pre-packed pods will provide an easier, more consistent experience, from purchase to inhalation.

CannaKorpis going to upgrade the whole experience of using medical marijuana,” stated Michael Bourque, CannaKorp co-founder and president. “Our goal is to simplify and improve the medical marijuana experience for millions of users worldwide. Patients don’t always know exactly what they are buying and preparing cannabis is an archaic process today. Used together, our CannaCloud vaporizer and CannaCups solve this problem.”

Revealed at the 4th Annual Marijuana Business Expo in Las Vegas, the patent-pending CannaCloud™ system uses CannaCup™ pods that contain pre-measured cannabis, environmentally sealed and available in dozens of varieties. 

According to Dave Manly, CannaKorp CEO and former senior vice president of Keurig, “The CannaCloud system reminds me a lot of the early days at Keurig—it offers a similar consumer proposition of speed and convenience and consumers exposed to the CannaCloud really love it.”

The company does not grow or distribute cannabis, but rather partners with authorized growers and processors. These partners are aligned with CannaKorp’s high standards for growing, testing, and filling pods with medicinal-use cannabis. The CannaCloud system is planned for release in fall 2016 [Source]

Read more…

Cliff Maynard's Roach Paper Art

The leftover butt from a marijuana cigarette "or roach" has several different shades of brown on it. What Cliff does is save these paper scraps or "roach papers" and use the brown tones as jis "palate". He tears or trims away the unwanted bits and uses just the parts he likes. It's a lot like working a jigsaw puzzle, but way harder and far more time consuming.

​All of Cliff's original artwork is made from just roach papers and nothing else. No pen, marker, or paint of any kind is used during the process. He is always on the look out for new raw materials so feel free to save-em up and he'll use them in his next project.

You can view Cliff's work at roachpaperart.com  [Video Source]

Read more…

Chris "The Herbal Chef" Sayegh must prepare a dinner for his influencer guests with one major hitch: He has no idea what ingredients he'll have until it is time to cook! That is, except for the surprise ingredient he brought, which will either disrupt or elevate the entire experience. Oh, and he is super baked the entire time. 

“The thing I love most about Pot Pie is that I get to be my goofy self and have fun,” says Sayegh about the new series. “I [normally] never get high and cook for my diners. I have so much to do that I need to be laser focused, but Pot Pie allows me to show that I can loosen up. Not to mention, I'm working with comedians and celebrities who make it so much fun to film.”

In this first episode, influencers Aristotle and Adrienne Airhart join The Herbal Chef in the kitchen. [Source]

Read more…

Laura Lagano, MS, RDN, CDN is an Integrative Clinical Nutritionist based in New Jersey. She has advanced training in functional medicine, which has her positioned her to become one of the first certified RDNs with the Institute of Functional Medicine. Boasting years of experience in food, nutrition + wellness communications, as well as in health curricula and continuing medical education development, Laura possesses a unique combination of science and communications savvy.

Laura is co-founder of the http://holisticcannabisnetwork.com

Holistic Cannabis Summit: http://holisticcannabissummit.com

[Source]

Read more…

"When The New York Times says we should legalize marijuana, I think maybe I should re-evaluate my position," jokes Reason senior editor Jacob Sullum, who spoke with Reason TV about the remarkable evolution of national drug policy over the last 25 years.

During the "Just Say No!" years of the 1980s, less than a quarter of Americans supported the legalization of marijuana. Today, even presidential candidates eager to claim the legacy of drug warrior Ronald Reagan are relaxing their views on prohibition.

“When they repealed alcohol prohibition, it was left up to the states what to do with alcohol,” says Sullum. “And so you have most of the Republican presidential candidates saying the federal government should not interfere if the states want to legalize. That’s really an amazing development.”

By contrast, progressives have been critics of the war on drugs, he says. It's only when marijuana becomes an industry, run by capitalists, that the left get uneasy. Libertarians and progressives tend to spar over the nature of regulation of the drug business, not the need for or desirability of legalization itself.

In 2016, recreational marijuana reform may be on the ballot in nearly a dozen states and Sullum is optimistic. With support for recreational marijuana polling at a record-high 58 percent, it's only a question of how many states legalize in next year's elections.

Sullum believes that California, the first state to legalize medical marijuana in 1996, is the best bet for passage and the most influential state in play. "There's a good shot it's going to pass. It's kind of surprising that California has not legalized marijuana by now," says Sullum, who is also the author of Saying Yes: In Defense of Drug Use, a nationally syndicated columnist, a drug-policy blogger at Forbes. [Source]

Read more…

The $1 trillion War on Drugs launched by President Nixon in 1971 created the Mexican drug cartels, now legalizing weed is killing them.

Nick Bernabe
March 4, 2016

(ANTIMEDIA) The Mexican drug cartels are finally meeting their match as a wave of cannabis legalization efforts drastically reshapes the drug trafficking landscape in the United States. It turns out that as states legalize cannabis use and cultivation, the volume of weed brought across the border by Mexican drug cartels dramatically decreases — and is putting a dent in their cash flow.

A newly-released statistical report from the U.S. Border Patrol shows a sharp drop-off in cannabis captured at the border between the United States and Mexico. The reduction in weed trafficking coincides with dozens of states embracing cannabis use for both medical and recreational purposes.

In fact, as the Washington Post reports, cannabis confiscations at the southern border have stumbled to the lowest point in over a decade — to only 1.5 million pounds. That’s down from a peak of four million pounds in 2009. [Read More]

Read more…

If upcoming study results are positive, people with multiple sclerosis may have a marijuana gum available for treatment of symptoms by 2017. The gum is made by AXIM Biotechnology, Inc. and is called MedChew Rx.

The marijuana gum has been tested for treatment of pain and spasticity in multiple sclerosis, and the company expects the Food and Drug Administration and the European Medicines Agency to approve the product for this use. MedChew Rx contains 5 mg of cannabidiol (CBD) and 5 mg of tetrahydrocannabinol (THC) and will be available by prescription.

Cannabidiol is one of more than 100 cannabinoid chemicals found in marijuana plants. It does not make people high and has been shown to possess multiple health benefits, including an ability to treat seizures and other neurological conditions. THC, another type of cannabinoid, has psychoactive properties as well as medicinal abilities.

[Source]

Read more…

This January, New York became the 23rd state to legalize the use of prescription cannabis. For this video, TIME went inside one of the first medical marijuana dispensaries, Vireo Health, which has one of the state’s five licenses to grow and sell medical cannabis.

Unlike other states that have passed medical marijuana legislation, New York prohibits marijuana for smoking. Instead, it allows the drug to be sold in liquid or in oil form, for use in vaporizers, or in capsules that can be taken orally. The program is only for patients with very serious or terminal illnesses, including cancer, HIV or AIDS, amyotrophic lateral sclerosis (ALS), and Parkinson’s disease. New York is also limiting the number of dispensaries to 20–far fewer than the hundreds in states such as California and Colorado.

Critics say that the small number of dispensaries will restrict patient access to the drug and that New York has gone too far in limiting the types of patients allowed in the program, while state officials say the more restrictive approach will ensure that it remains a medical, and not commercial, market.

[Source]

Read more…

Cannabis 101: Visual Quality Guide [Video]

Leafly's Cannabis 101 breaks down some important visual cues to look for when purchasing cannabis. Quality standards may vary depending on you location and access to cannabis and there are many other attributes to consider when buying cannabis. Besides the appearance the smell, effects, price, and quantity available may also influence your choice when selecting a strain. Potent cannabis doesn't necessarily mean it's high quality if it's missing the flavors or effects that you are looking for. Test data can also go a long way towards understanding what to expect from the cannabis you chose.

Explore more about cannabis quality at leafly.com

[Source]

Read more…

Hugh Hempel is a technology industry veteran turned health care entrepreneur. In this moving talk he discusses how medicinal cannabis has enriched the lives of his ailing 11 year-old daughters. This talk will challenge your views of medical marijuana

Hugh Hempel is a technology industry veteran turned healthcare entrepreneur. During his 30-year career in high technology, Hugh has held numerous senior management positions in many innovative and pioneering technology companies.

As chief operating officer and co-founder of Hopelink, Hugh launched one of the first Healthcare Internet start-ups that matched cancer patients with online clinical trials. Prior to founding Hopelink, Hugh held a variety of positions at Netscape, the first successful consumer Web browser software company. As Director of Online Marketing and Director of Enterprise Sales and Marketing, Hugh worked with the team that helped make the Web a reality for millions of people worldwide.

Prior to joining Netscape, Hugh worked as Manager of Engineering and Science markets for Apple Computer. While at Apple, he helped define the Apple Newton Messagepad, Apple’s first handheld computer that was a revolution in personal computing.

Hugh also held the position of Director at Computervision, an early pioneer in Computer Aided Design and Manufacturing (CAD/CAM) software used by companies around the world to develop automotive and aerospace products. Hugh’s first job in the technology industry was as a National Accounts Representative for IBM after graduating with a B.S. in Engineering Management from the University of Vermont.

In 2006, Hugh’s 10 year old identical twin daughters were diagnosed with a rare and fatal neurodegenerative disease called Niemann Pick Type C, often referred to as “Childhood Alzheimer’s.” Since that time, Hugh and his wife Chris have immersed themselves in science and medicine and discovered through their own research that a simple sugar compound called cyclodextrin could save their twins’ lives. As parents, they successfully filed applications with U.S. Food and Drug Administration (FDA) and received permission to try this never before used treatment on their daughters.

The Hempel’s journey to develop cyclodextrin has made international headlines and was recently featured in The Wall Street Journal in a 10 chapter story entitled, “A Desperate Fight to Save Kids and Change Science,” as well as in a documentary called “Here. Us. Now.” More information can be found at http://projects.wsj.com/trials and http://here-us-now.com/.

In 2009, Hugh and his wife Chris became interested in Cannabidiol (CBD), one of at least 80 active cannabinoids identified in marijuana and hemp, as his twins suffer from intractable seizures as a result of their disease and experience up to a 100 seizures a week. Through extensive research, they learned that cannabinoid receptors are involved in a vast array of functions in the body, including helping to control brain and nerve activity (including memory and pain), energy metabolism, heart function, and the immune system. After realizing pharmaceutical grade cannabis products were unavailable for their daughters and other patients in Nevada, the Hempel’s decided to create a Nevada based “cannabusiness” focused on legally developing and distributing high-quality flowers, extracts and concentrates at competitive prices.

Hugh sits on the Board of Directors for The Global Genes Project, a leading rare and genetic disease non-profit advocacy organization based in California. He is a frequent speaker on a variety of healthcare topics including small clinical trial design, new drug discovery, and patient reported outcome systems for more efficient clinical research.

Hugh aims to create a large scale cannabis clinical research clearing house in an effort to better elucidate the potential benefits of this cannabis plant. Until such time as there are readily available quality cannabis medicinal products on the market, this goal is nearly impossible. The creation of a pharmaceutical quality cannabis supply network is the first step towards this larger goal of building knowledge about using cannabis to improve health.

[Source]

Read more…